Softwr

Research · head to head

LabWare vs Remesh

LabWare logo

LabWare

Research

Enterprise laboratory information management system for regulated labs

From
On request
Rated
-
Full reviewWebsite
Remesh logo

Remesh

Research

Live AI-moderated conversations with hundreds of participants at once, analysed in real time

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: LabWare implementation and validation take a year or more, and the services cost frequently exceeds the licence; Remesh pricing is not published and third-party estimates put annual contracts in the tens of thousands of dollars, which puts it out of reach for teams that only run occasional qualitative studies and cannot commit to an annual platform fee.
  • They diverge on capability: LabWare covers Sample management, Remesh covers Live moderated sessions.
  • Prices and features above were last checked on 31 August 2026.

Where they differ

Only the attributes on which LabWare and Remesh actually diverge.

Attributes where LabWare and Remesh differ
AttributeLabWareRemesh
PlatformsWindows, Web, Cloud, On-premiseWeb, API

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in LabWare

  • Sample management
  • Instrument integration
  • Regulatory compliance
  • Stability studies
  • ELN
  • Configuration framework

Only in Remesh

  • Live moderated sessions
  • Collective dialogue
  • Flex asynchronous studies
  • Video research
  • Remy AI assistant
  • On-Demand Recruit
  • Real-time theme analysis
  • Practice sessions

What people use each for

The jobs each tool is most often brought in to do.

LabWare

  • Pharmaceutical quality control laboratories subject to regulatory inspectionnot Remesh
  • Multi-site laboratory networks needing one method and specification librarynot Remesh
  • Contract laboratories managing chain of custody across many clientsnot Remesh
  • Laboratories replacing a validated legacy LIMS they can no longer maintainnot Remesh

Remesh

  • A brand team that needs to test three positioning statements with 400 target customers and know by the end of the day which one lands and with whomnot LabWare
  • An HR function running an employee listening session across several thousand staff where anonymity and volume both matternot LabWare
  • A public affairs team needing rapid citizen consultation on a policy option with evidence of how widely each objection is heldnot LabWare
  • An insights team that has to replace six focus groups with one session because fieldwork time has been cut and the decision cannot waitnot LabWare

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

LabWare

  • Implementation and validation take a year or more, and the services cost frequently exceeds the licence
  • Pricing is entirely quote-based with no public reference point, even by enterprise standards
  • Extensive configuration means the finished system depends heavily on implementation quality, and outcomes vary widely between customers
  • The interface is functional rather than modern, which is a common objection from scientists used to consumer software
  • Substantially over-specified for research laboratories without regulatory obligations

Remesh

  • Pricing is not published and third-party estimates put annual contracts in the tens of thousands of dollars, which puts it out of reach for teams that only run occasional qualitative studies and cannot commit to an annual platform fee.
  • The public review picture is inconsistent in a way worth investigating: a small number of positive buyer reviews on G2 sit alongside a poor Trustpilot rating driven mostly by participant complaints, so ask directly how participants are recruited and compensated before running a study on your own customers.
  • Funding has slowed sharply, from a 25 million USD round in 2021 to a 4.25 million USD round in late 2022, so procurement teams at large organisations should expect to run a vendor viability review.
  • The collective dialogue mechanic rewards views that many participants recognise and vote for, which systematically under-weights genuinely novel minority insight, so it is a poor fit for exploratory discovery work where the outlier is the point.
  • The discussion guide builder, especially spreadsheet import, is reported as unreliable, and because sessions are live with recruited participants a tooling failure during setup is expensive rather than merely annoying.

Pricing, plan by plan

LabWare

On request
  • LabWare LIMS$undefined/year
    • Sample management
    • Instrument integration
    • Regulatory compliance

Remesh

On request
  • Remesh$undefined/year
    • Live moderated sessions
    • Flex asynchronous studies
    • Video research

Which should you pick?

Choose LabWare if

  • You need sample management.
  • You work on Windows, Web, Cloud, On-premise.
  • You also want instrument integration.
LabWare review

Choose Remesh if

  • You need live moderated sessions.
  • You work on Web, API.
  • You also want collective dialogue.
Remesh review

Questions people ask

Is LabWare or Remesh better?
Neither clearly leads. LabWare starts at On request and Remesh at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, LabWare or Remesh?
LabWare starts at On request and Remesh at On request.
Does LabWare or Remesh run on more platforms?
LabWare runs on Windows, Web, Cloud, On-premise. Remesh runs on Web, API.
What is LabWare best used for?
LabWare is most often used for pharmaceutical quality control laboratories subject to regulatory inspection, multi-site laboratory networks needing one method and specification library, contract laboratories managing chain of custody across many clients, laboratories replacing a validated legacy lims they can no longer maintain. Of those, pharmaceutical quality control laboratories subject to regulatory inspection and multi-site laboratory networks needing one method and specification library are not what Remesh is typically brought in for.
What can LabWare do that Remesh cannot?
LabWare covers Sample management, Instrument integration, Regulatory compliance, Stability studies. Remesh covers Live moderated sessions, Collective dialogue, Flex asynchronous studies, Video research.

Answered from the vendors’ own pages

LabWare: Why is LabWare so dominant in pharma?

Validation experience. In a regulated laboratory the software forms part of what an inspector examines, and decades of accumulated validation practice is not something a newer vendor can substitute for.

Remesh: How many people can join one session?

Sessions are designed for several hundred participants at once, which is the core reason to choose it over a conventional focus group.

LabWare: What does it cost?

Not published. Enterprise licensing plus implementation and validation services, and the services frequently exceed the licence.

Remesh: Does it publish pricing?

No. Contracts are quoted annually, typically scoped by session volume, and third-party estimates place them in the tens of thousands of dollars per year.

LabWare: How long is implementation?

A year or more for a regulated laboratory, including validation. Anyone quoting substantially less is either scoping narrowly or omitting validation.

Remesh: Can it replace a survey?

Not entirely. It produces open-ended language with agreement percentages, which is stronger than a survey for understanding reasoning but weaker for precise population estimates.

LabWare: Does it include an electronic laboratory notebook?

Yes, LabWare offers ELN alongside LIMS on the same platform, which avoids the integration problem of running two vendors.

Remesh: Does Remesh recruit participants for me?

Yes, through On-Demand Recruit, typically delivering a panel within about 24 hours, or you can bring your own list.

LabWare: Is it suitable for a research lab?

Usually not. Research laboratories without regulatory obligations pay for compliance machinery they do not need, and Benchling or a lighter LIMS fits better.

Share

Related pages

More on LabWare

More on Remesh

Keep looking

Other head to heads